The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chatila, T.
Right arrow Articles by Geha, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chatila, T.
Right arrow Articles by Geha, R.

The Journal of Immunology, Vol 143, Issue 4 1283-1289, Copyright © 1989 by American Association of Immunologists

ARTICLES

Mechanisms of T cell activation by the calcium ionophore ionomycin

T Chatila, L Silverman, R Miller and R Geha
Division of Immunology, Children's Hospital, Boston, Massachusetts 02115.

We have investigated signaling mechanisms that may underlie the T cell mitogenic properties of the Ca2+ ionophore ionomycin. Ionomycin induces highly purified resting human T cells to proliferate in the presence of monocytes with accompanying IL-2R expression and IL-2 synthesis. Treatment of T cells with ionomycin triggers the hydrolysis of phosphoinositides, as evidenced by the accumulation of the hydrolytic by-products phosphatidic acid and inositol phosphates. Ionomycin also induces the activation of protein kinase C (PKC), as demonstrated by the auto-phosphorylation of PKC and the phosphorylation of the PKC target proteins CD4 and CD8. Ionomycin synergizes with PMA in enhancing the activation of PKC. It is concluded that, in addition to its putative activation of Ca2+/calmodulin-dependent signaling pathways, ionomycin induces the hydrolysis of phosphoinositides and the activation of PKC in human T cells. The synergy of ionomycin with phorbol esters in triggering T cell activation may relate, at least in part, to enhanced activation of PKC.


This article has been cited by other articles:


Home page
 J. Immunol.Home page
B. R. Schram, L. E. Tze, L. B. Ramsey, J. Liu, L. Najera, A. L. Vegoe, R. R. Hardy, K. L. Hippen, M. A. Farrar, and T. W. Behrens
B Cell Receptor Basal Signaling Regulates Antigen-Induced Ig Light Chain Rearrangements
J. Immunol., April 1, 2008; 180(7): 4728 - 4741.
[Abstract] [Full Text] [PDF]

Home page
 Infect. Immun.Home page
C. O. Deetz, A. M. Hebbeler, N. A. Propp, C. Cairo, I. Tikhonov, and C. D. Pauza
Gamma Interferon Secretion by Human V{gamma}2V{delta}2 T Cells after Stimulation with Antibody against the T-Cell Receptor plus the Toll-Like Receptor 2 Agonist Pam3Cys.
Infect. Immun., August 1, 2006; 74(8): 4505 - 4511.
[Abstract] [Full Text] [PDF]

Home page
 Int ImmunolHome page
C. S. Chin, C. H.T. Miller, L. Graham, M. Parviz, S. Zacur, B. Patel, A. Duong, and H. D. Bear
Bryostatin 1/ionomycin (B/I) ex vivo stimulation preferentially activates L-selectinlow tumor-sensitized lymphocytes
Int. Immunol., September 1, 2004; 16(9): 1283 - 1294.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1989 by The American Association of Immunologists, Inc. All rights reserved.